Meet our Senior Management Team
Patient-First: We are a medical device and healthcare company that is passionate about making patients’ lives more comfortable. At Trudell, all things start with the patient.
George has over 30 years of experience in the medical device industry. His responsibilities have included both business and technical leadership in the acquisition and development of novel medical device technologies...
George has been responsible for the pre-clinical marketing of new drug delivery technologies to medical opinion leaders and major pharmaceutical companies. This has included collaboration with business and clinical partners in the design and co-ordination of pre-clinical studies.
George has been granted several US and international patents for medical devices for drug delivery and minimally invasive surgery. He holds an MBA from the Richard Ivey School of Business, Western University, London (ON) where he currently serves on the Advisory Board of the Lawrence National Centre for Policy and Management. George serves as Executive Chairman of the Trudell Medical Limited Board of Directors.
In addition to his role at Trudell, George is a Director of Vanrx Pharmasystems Inc., Sensory Technologies, Mozzaz Corporation, and Sky Medical Technology Inc. He is also founder and President of Perfuse Medtec Inc. a Canadian medical device market development company.
Respect means being tolerant and considering other people’s opinions even when we don’t agree with them. It means treating people the same way they want to be treated. To function well as an organization, we must respect each other.
Gerald is currently CEO of Trudell Medical Limited, a diversified medical devices company with operations in respiratory care, minimal invasive surgery, medical device distribution and home oxygen. He was formerly President and CEO of Cuddy International Corporation, an international poultry company...
Gerald is an Ivey HBA graduate, Western University, London (ON) and began his career with PriceWaterhouseCoopers. After obtaining his CA, he left to pursue entrepreneurial ambitions. He acquired a small company and built it into the largest provider of private label roadside assistance in Canada and brought nurse-based telehealth to Ontario. Gerald was also a founding partner and Chair of Technology Investment Management Corporation, which managed a venture capital fund. He is currently on the Board of several companies including EllisDon Corporation where he is Chair of the Board.
Gerald also has a strong record of community involvement currently serving as a board member of The London Club and Huron College. He is Past Chair of the Board of Directors of the London Economic Development Corporation, formerly President of the Grand Theater Foundation as well as the Boys & Girls Club Foundation, and past member of the board of Operation Walk Canada.
VP Business Development, General Counsel, Director
Joaquim is Vice President, Business Development and General Counsel of Trudell Medical Limited. He has over 23 years of global medtech experience with a proven track record in innovation, IP strategy, strategic business alliances, negotiation of complex international transactions, acquisitions, dispute resolution, and overall management of the legal and BD functions...
Joaquim joined Trudell in 1996 as its Director of Legal Affairs and has been part of Trudell’s growth trajectory from 250 employees in 1996 to today’s close to 1,000 employees. Joaquim joined the Board in August 2018.
Prior to joining Trudell, Joaquim practiced corporate, commercial and IP law at a leading law firm in London (ON) and worked as a business research analyst and money market manager at a leading insurance company in Helsinki, Finland.
Joaquim is an active participant in the community. He is currently a member of the Board of Directors and of the executive committee of the Ontario Chamber of Commerce and is the chair of its Finance, Audit and Risk committee. He is also the co-Chair of the City of London’s Advisory Body which oversees the implementation of the City’s Newcomer Strategy. He is also a member of several professional associations, including the Licensing Executives Society and Association of Corporate Counsel.
Joaquim holds a B.Com. International Business Major (with distinction) from Concordia University, Montreal (PQ), a law degree (J.D.) from Queen’s University, Kingston (ON), an MBA from the Richard Ivey School of Business, Western University, London (ON), and a D.E.C. in Pure and Applied Sciences. In addition to English, he is also fluent in French, Spanish, and Catalan.
Ours is a business where integrity is evident through actions taken over decades and has truly been core to our success. A strong reputation and relationships have been earned across our teams, partners and patients by consistently choosing to do what’s right.
Calvin joined Trudell Medical Limited in June 2017, transitioning from Calgary to London. Prior to joining Trudell, Calvin served as Senior Vice-President and Chief Financial Officer at Parkbridge Lifestyle Communities, Canada’s largest, owner, developer and operator of land lease...
Calvin participated in Parkbridge’s multi-year industry consolidation, culminating in a successful mid-cap privatization transaction, and the public company’s transition to institutional ownership (B.C. Investment Management Corp.).
Calvin earned his C.P.A. designation at Deloitte and Touché (Winnipeg) and Ernst & Young (Bermuda, Calgary), eventually concentrating on Shaw Communications and other technology clients. After obtaining his designation, Calvin developed a compliance and risk consulting practice serving Calgary energy clients. Calvin has also acted as C.F.O. at WinSport (Calgary), owner and operator of Canada Olympic Park (1988 Games legacy assets). Past Director roles have included seniors’ resource and family recreational facilities in Calgary (AB).
Trust must be earned. Where trust is present and continually developed, wonderful things can happen. We truly appreciate the opportunities that trust generates at Trudell.
Jim leads the investment management group with the Trudell Group of companies. He is responsible for managing the investment portfolios of Trudell Medical Limited and the Mitchell & Kathryn Baran Family Foundation...
Prior to his promotion to VP, Jim had worked closely with founder Mitch Baran over a 12-year period as Director of Investments. Jim started his career at Trudell as Director of Tax and Treasury in 2001, a new operational position he was instrumental in creating, following a one-year contract in Accounting and Finance.
Aside from being a CFA Charter holder, Jim is a CPA, and worked previously as an auditor at KPMG in Toronto (ON) and tax manager at EY & TD in London. Jim holds a BBA degree (Co-op) from Wilfrid Laurier University, Waterloo (ON).
Jim has served on the Board of Children’s Health Foundation (CHF) as Treasurer and was nominated Honorary Director of the Foundation. He is a current member, and previous Chair of the CHF Investment Committee. Jim previously served on the St. Joseph’s Healthcare Resource Planning Committee and chaired the Investment Committee. Jim is also a current member of the London Community Foundation Grants Committee.
Duty means believing in and committing to something beyond ourselves. It shows up when we serve our patients and customers, and when we support each other to achieve shared goals.
Director, People and Culture
Debbie’s curiosity in the people part of business, and her interest in aligning goals of individuals with goals of organizations have made it possible for her to work as an HR practitioner alongside farmers, scientists, millwrights, accountants, etc. in environments as varied as her colleagues...
Debbie's career to date includes progressively responsible HR roles with Cuddy Food Products (now operating as Cargill Value Added Meats, and Sofina Foods Inc.), and HR management at Cold Springs Farm Limited (now operating as Maple Leaf Foods). Debbie joined Trudell Medical International in 2007 to support the growth in size, scope, and diversity of the business and its workforce.
Debbie transitioned to Trudell Medical Limited as Director, People and Culture in 2019 where she works with senior and HR leaders across the Trudell Medical Group to integrate systems and processes that promote a high-performance team culture grounded in the Company’s values.
Dominick Arena has been both an Operating Partner and an Executive Advisor to Waterstreet Healthcare Partners a private equity company focused strictly on healthcare since 2006. He has more than 30 years of experience growing small start-ups and large multi-national corporations. Prior to Water Street, Dominick was president of Smiths Medical Critical Care, a leading global provider of medical devices.
Previously, he was President and CEO of Medex, Inc. At Medex, Dominick led a successful management buyout of the company and completed a number of strategic acquisitions to build the company into a leading global manufacturer of critical care medical products.
Dominick also served as the leader of three medical device manufacturing companies: Hudson Respiratory Care, Inc., Respiratory Care, Inc., and AnaMed International. He also led the healthcare business of the Furon Company.
Dominick began his career in the healthcare industry working for Baxter and The Kendall Corporation, where he was promoted to executive-level positions.
Dominick currently serves on the boards of Trudell Medical Limited, ZALEA, LLC, and Implantdata. He also is a member of the board of the Waldorf School of San Diego. Dominick received a bachelor’s degree in chemistry from LeMoyne College before serving his country in both the United States Army and the Central Intelligence Agency.
Dominick joined the Trudell Board in 2016.
Peter Curry has had a successful 30-year career in medical devices spanning operations, sales, marketing and general management in Canada and the United States.
Most recently, Peter has retired from 19 years with CR BARD, holding various executive leadership roles. Throughout these roles, he effectively built strong performance cultures focused on sustainable growth and led new business expansions in China, Brazil, Turkey, Russia and Saudi. In addition, to his time at CR BARD, Peter held various roles at Zimmer Canada, VASCATH Inc., Ingram & Bell.
He graduated from Mechanical Engineering at Western University and obtained an Executive MBA from the Richard Ivey School of Business, Western University, London (ON).
Peter joined the Trudell Board in September 2018.
Rob Harris has over 35 years of pharmaceutical industry experience in both Canada and the United States in sales, marketing, business development and general management. Rob most recently served as President and CEO of Tribute Pharmaceuticals. Prior to co-founding Tribute Pharmaceuticals, he was the President & CEO of Legacy Pharmaceuticals Inc. Rob also has previous experience at Biovail Corporation where as VP of Business Development he was involved, led and successfully concluded numerous business development transactions, including the licensing of new chemical entities, the acquisition of mature products, the completion of co-promotion deals, distribution agreements, product development and reformulation transactions. Rob joined Biovail in 1997 as the GM of Biovail Pharmaceuticals Canada at a time when the company experienced rapid growth in the Canadian division. Before Biovail, Rob worked in various senior commercial management positions during his twenty-year tenure at Wyeth (Ayerst) including its animal health group and has been involved in numerous product launches during his career.
Rob also serves as a member of the Board of Directors of Nuvo Pharmaceuticals Inc. and a former director at Origin House, Tribute Pharmaceuticals and Aralez Pharmaceuticals Inc. He is also a member of the Board of Directors at Grey Wolf Animal Health, which is privately held.
Rob joined the Trudell Board in November 2018.
Guy Payette is the President and Founder of Innomar Strategies Inc., Canada’s leading integrated service provider for specialty pharmaceutical manufacturers. Innomar was sold to AmerisourceBergen.
With over 25 years of experience in sales, marketing, market access, and government relations, Guy’s career spans all facets of the pharmaceutical industry. Before Innomar, Guy was a senior executive at Boehringer Ingelheim for over 12 years.
Guy joined the Trudell Board in June 2016.
Martin (Marty) Thrasher
Marty Thrasher is currently President of FMT Consulting, a boutique management advisory and consulting firm specializing in the packaged goods industry. It is based in London (ON) and has been in business since 2004.
Marty is a seasoned international executive. After graduating in 1973 with an HBA from the Richard Ivey School of Business, Western University, London (ON), he spent over 30 years working around the globe for such blue-chip food companies as General Foods, McCormick & Co, Campbell Soup Co, and ConAgra Foods Inc. He lived and worked in Canada, Australia, Belgium and the USA. His responsibilities with Campbell Soup included positions as President, International and President, North America. At ConAgra, he was President of the Retail Products Co, a $9 billion business with over 30,000 employees.
As President of FMT Consulting, he has advised numerous organizations in a variety of industries in both North America and abroad. He has successfully completed roles as interim Executive Chairman and CEO plus has extensive experience as a Director for both public and private company Boards.
Marty joined the Trudell Board in June 2017.
Since his retirement in 2014 from Boehringer Ingelheim Canada where he was President and CEO, Ted has taken on the role as a healthcare advisor and scholar based in Toronto (ON) and Lisbon (PT). His is a Professor and Senior Fellow at University of Toronto’s School of Public Health. Ted has earned a BSc from Quinnipiac College, an MPH from Yale, his DrPH from Columbia in NYC and MBA from Henley in London (UK). He has published over 100 manuscripts and chapters in respiratory and drug development area; he has expertise in obstructive airway disease and has been a major contributor to the field of cough, cold & allergy.
Ted joined the Trudell Board in 2014.